Objectives: Human papilloma virus (HPV) has been repeatedly found in esophageal carcinoma tissues. However, detection rates of HPV DNA in these tumors have varied markedly. Differences in detection methods, sample types and geographic regions of the sample origin have been suggested as potential causes of this discrepancy. This study was undertaken to analyze the prevalence of HPV in esophageal carcinoma. Study Design: HPV L1 DNA was evaluated in a total of 49 esophageal carcinoma samples, including 44 cases of squamous cell carcinoma (SCC) and 5 cases of adenocarcinoma. Seventeen control samples of esophageal brushings were also analyzed. The HPV L1 fragment was detected using MY09/MY11 primers. Results: In test samples, 17/49 (34.7%) were positive for HPV L1 and, in comparison, none of the control samples were positive. HPV DNA was identified in 17/37 (46%) cases of non-keratinizing SCC and was not identified in any case of esophageal keratinizing SCC and adenocarcinoma. Conclusion: This study defines a significant association of HPV with esophageal non-keratinizing SCC. Our findings raise the possibility that HPV is involved in esophageal carcinogenesis, especially the non-keratinizing type of SCC. Further investigation with a larger sample size over broader geographic areas may be warranted.

Keywords:
Polymerase chain reaction, Squamous cell carcinoma, Esophageal carcinoma, Human papilloma virus
1.
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al: SEER Cancer Statistics Review, 1975–2000. Bethesda, National Cancer Institute, 2003.
2.
Li MH, Li P, Li PJ: Recent progress in research on esophageal cancer in China. Adv Cancer Res 1980;33:173–249.
3.
Li JY: Epidemiology of esophageal cancer in China. Natl Cancer Inst Monogr 1982;62:113–120.
4.
Siddiqi M, Preussmann R: Esophageal cancer in Kashmir – an assessment. J Cancer Res Clin Oncol 1989;115:111–117.
5.
Ferlay J, Bray F, Pisani P, Parkin D: GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Version 1. Lyon, IARC Press, 2001.
6.
Chitra S, Ashok L, Anand L, Srinivasan V, Jayanthi V: Risk factors for esophageal cancer in Coimbatore, Southern India: a hospital-based case-control study. Indian J Gastroenterol 2004;23:19–21.
7.
Guo W, Blot WJ, Li JY, Taylor PR, Liu BQ, Wang W, et al: A nested case-control study of esophageal and stomach cancers in the Linxian nutrition intervention trial. Int J Epidemiol 1994;23:444–450.
8.
Yang CS: Research on esophageal cancer in China: a review. Cancer Res 1980;40:2633–2644.
9.
Notani PN: Role of alcohol in cancers of the upper alimentary tract: use of models in risk assessment. J Epidemiol Community Health 1988;42:187–192.
10.
Syrjanen K, Pyrhonen S, Aukee S, Koskela E: Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol 1982;5:291–296.
11.
Chang F, Syrjanen S, Shen Q, Ji HX, Syrjanen K: Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China. Int J Cancer 1990;45:21–25.
12.
Benamouzig R, Pigot F, Quiroga G, Validire P, Chaussade S, Catalan F, et al: Human papillomavirus infection in esophageal squamous-cell carcinoma in western countries. Int J Cancer 1992;4:549–552.
13.
Chang F, Syrjanen S, Shen Q, Wang L, Wang D, Syrjanen K: Human papillomavirus involvement in esophageal precancerous lesions and squamous cell carcinomas as evidenced by microscopy and different DNA techniques. Scand J Gastroenterol 1992;27:553–563.
14.
Furihata M, Ohtsuki Y, Ogoshi S, Takahashi A, Tamiya T, Ogata T: Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer 1993;54:226–230.
15.
Khurshid A, Kazuya N, Hanae I, Manabu I: Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma. J Pak Med Assoc 1998;48:138–142.
16.
Chang F, Syrjanen S, Shen Q, Cintorino M, Santopietro R, Tosi P, et al: Evaluation of HPV, CMV, HSV and EBV in esophageal squamous cell carcinomas from a high-incidence area of China. Anticancer Res 2000;20:3935–3940.
17.
Farhadi M, Tahmasebi Z, Merat S, Kamangar F, Nasrollahzadeh D, Malekzadeh R: Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol 2005;11:1200–1203.
18.
Syrjanen KJ: HPV infections and esophageal cancer. J Clin Pathol 2002;55:721–728.
19.
Villa LL: Human papillomaviruses and cervical cancer. Adv Cancer Res 1997;71:321–341.
20.
Syrjanen KJ: Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch Geschwulstforsch 1982;52:283–292.
21.
Winkler B, Capo V, Reumann W, Ma A, La Porta R, Reilly S, et al: Human papillomavirus infection of the esophagus. A clinicopathologic study with demonstration of papillomavirus antigen by the immunoperoxidase technique. Cancer 1985;55:149–155.
22.
Mori M, Shimono R, Inoue T, Kuwano H, Sagimachi K, Zhang RG: Papillomavirus and esophageal cancer in the Japanese and Chinese. Am J Gastroenterol 1989;84:1126–1127.
23.
Toh Y, Kuwano H, Tanaka S, Baba K, Matsuda H, Sugimachi K, et al: Detection of human papillomavirus DNA in esophageal carcinoma in Japan by polymerase chain reaction. Cancer 1992;70:2234–2238.
24.
Kulski JK, Demeter T, Mutavdzic S, Sterrett GF, Mitchell KM, Pixley EC: Survey of histologic specimens of human cancer for human papillomavirus types 6/11/16/18 by filter in situ hybridization. Am J Clin Pathol 1990;94:566–570.
25.
Togawa K, Jaskiewicz K, Takahashi H, Meltzer SJ, Rustgi AK: Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. Gastroenterology 1994;107:128–136.
26.
Togawa K, Rustgi AK: Human papillomavirus-16 and -18 replication in esophagus squamous cancer cell lines does not require heterologous E1 and E2 proteins. J Med Virol 1995;45:435–438.
27.
Kiyabu MT, Shibata D, Arnheim N, Martin WJ, Fitzgibbons PL: Detection of human papillomavirus in formalin-fixed, invasive squamous carcinomas using the polymerase chain reaction. Am J Surg Pathol 1989;13:221–224.
28.
Sobti RC, Kochar J, Singh K, Bhasin D, Capalash N: Telomerase activation and incidence of HPV in human gastrointestinal tumors in North Indian population. Mol Cell Biochem 2001;217:51–56.
29.
Smits HL, Tjong AHSP, ter Schegget J, Nooter K, Kok T: Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions. J Med Virol 1995;46:213–215.
30.
Williamson AL, Jaskiesicz K, Gunning A: The detection of human papillomavirus in esophageal lesions. Anticancer Res 1991;11:263–265.
31.
Mizobuchi S, Sakamoto H, Tachimori Y, Kato H, Watanabe H, Terada M: Absence of human papillomavirus-16 and -18 DNA and Epstein-Barr virus DNA in esophageal squamous cell carcinoma. Jpn J Clin Oncol 1997;27:1–5.
32.
Takahashi A, Ogoshi S, Ono H, Ishikawa T, Toki T, Ohmori N, et al: High-risk human papillomavirus infection and overexpression of p53 protein in squamous cell carcinoma of the esophagus from Japan. Dis Esophagus 1998;11:162–167.
33.
Loke SL, Ma L, Wong M, Srivastava G, Lo I, Bird CC: Human papillomavirus in esophageal squamous cell carcinoma. J Clin Pathol 1990;43:909–912.
34.
Tornesello ML, Monaco R, Nappi O, Buonaguro L, Buonaguro FM: Detection of mucosal and cutaneous human papillomaviruses in oesophagitis, squamous cell carcinoma and adenocarcinoma of the oesophagus. Clin Virol 2009;45:28–33.
35.
Iyer A, Rajendran V, Adamson CS, Peng Z, Cooper K, Evans MF: Human papillomavirus is detectable in Barrett’s esophagus and esophageal carcinoma but is unlikely to be of any etiologic significance. Clin Virol 2011;50:205–208.
36.
Syrjanen S: HPV infections and tonsillar carcinoma. J Clin Pathol 2004;57:449–455.
37.
Syrjänen S: Human papillomavirus in head and neck cancer. J Clin Virol 2005;32S:S59–S66.
38.
Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, Kumar S, Gopalkrishna V, Kumar N, Das BC: p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 2005;218:69–79.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.